24 May 2013
Keywords: arimidex, cuts, breast, cancer, recurrence, vs, tamoxifen
Article | 24 December 2007
John Forbes of the Newcastle Mater Misericordiae Hospital in Australia says that data from a long-term study of the anticancer ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
24 December 2007
17 December 2007
23 May 2013
© 2013 thepharmaletter.com